Literature DB >> 22762421

Short-course untargeted isoniazid preventive therapy in South Africa: time to rethink policy?

Stephen D Lawn, Robin Wood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22762421      PMCID： PMC3816248          DOI： 10.5588/ijtld.12.0364

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  5 in total

Review 1.  Scale-up of isoniazid preventive therapy in PEPFAR-assisted clinical sites in South Africa.

Authors:  C C Bristow; E Larson; A K Vilakazi-Nhlapo; M Wilson; J D Klausner
Journal:  Int J Tuberc Lung Dis       Date:  2012-06-05       Impact factor: 2.373

2.  6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial.

Authors:  Taraz Samandari; Tefera B Agizew; Samba Nyirenda; Zegabriel Tedla; Thabisa Sibanda; Nong Shang; Barudi Mosimaneotsile; Oaitse I Motsamai; Lorna Bozeman; Margarett K Davis; Elizabeth A Talbot; Themba L Moeti; Howard J Moffat; Peter H Kilmarx; Kenneth G Castro; Charles D Wells
Journal:  Lancet       Date:  2011-04-12       Impact factor: 79.321

3.  What is thwarting tuberculosis prevention in high-burden settings?

Authors:  Edward Nardell; Gavin Churchyard
Journal:  N Engl J Med       Date:  2011-07-07       Impact factor: 91.245

4.  New regimens to prevent tuberculosis in adults with HIV infection.

Authors:  Neil A Martinson; Grace L Barnes; Lawrence H Moulton; Reginah Msandiwa; Harry Hausler; Malathi Ram; James A McIntyre; Glenda E Gray; Richard E Chaisson
Journal:  N Engl J Med       Date:  2011-07-07       Impact factor: 91.245

Review 5.  Treatment of latent tuberculosis infection in HIV infected persons.

Authors:  Christopher Akolo; Ifedayo Adetifa; Sasha Shepperd; Jimmy Volmink
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20
  5 in total
  3 in total

1.  Performance of symptom-based tuberculosis screening among people living with HIV: not as great as hoped.

Authors:  Faiz Ahmad Khan; Sabine Verkuijl; Andrew Parrish; Fadzai Chikwava; Raphael Ntumy; Wafaa El-Sadr; Andrea A Howard
Journal:  AIDS       Date:  2014-06-19       Impact factor: 4.177

2.  One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.

Authors:  Susan Swindells; Ritesh Ramchandani; Amita Gupta; Constance A Benson; Jorge Leon-Cruz; Noluthando Mwelase; Marc A Jean Juste; Javier R Lama; Javier Valencia; Ayotunde Omoz-Oarhe; Khuanchai Supparatpinyo; Gaerolwe Masheto; Lerato Mohapi; Rodrigo O da Silva Escada; Sajeeda Mawlana; Peter Banda; Patrice Severe; James Hakim; Cecilia Kanyama; Deborah Langat; Laura Moran; Janet Andersen; Courtney V Fletcher; Eric Nuermberger; Richard E Chaisson
Journal:  N Engl J Med       Date:  2019-03-14       Impact factor: 91.245

3.  Scale-up of collaborative TB/HIV activities in Guyana.

Authors:  Brian J Baker; Brandy Peterson; Jeetendra Mohanlall; Shanti Singh; Collene Hicks; Ruth Jacobs; Ruth Ramos; Barbara Allen; Eric Pevzner
Journal:  Rev Panam Salud Publica       Date:  2017-04-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.